Avastin for PDR (Proliferative Diabetic Retinopathy)

• Status: Completed
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effect of anti-VEGF drug (Avastin) adminstration in eyes prior to surgical treatment for Traction retinal detachment (TRD) in patients with Proliferative Diabetic Retinopathy (PDR).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Southern California
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• Active fibrovascular proliferation due to PDR with TRD given pre-operative clearance for pars plana vitrectomy (PPV) and TRD repair.

Exclusion Criteria:

• Dense vitreous hemorrhage

• Inability to follow-up for surgery within 3-7 days after intravitreal injection

• History of stroke, thromboembolic event, or heart attack within the last 6 months

• Less than 18 years of age

• Pregnancy